Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study

Table 1 Patient characteristics

N. of patients	40
Median Age [year]	70 [56, 80]
Median Initial PSA [ng/mL]	6.25 [0.50, 13.43]
Median Gleason Score	6 [6,7]
NCCN Low Risk Class	26
NCCN Intermediate Risk Class	14
Median F-UP [months]	10 [3-14]
N. of patients with SpaceOAR™	8

ISSN: 1748-717X